Genesis Therapeutics

ML Research Intern, PhD - 2026

Sorry, this job was removed at 10:16 p.m. (CST) on Monday, Aug 04, 2025

Be an Early Applicant

2 Locations

In-Office

Artificial Intelligence • Biotech

The Role

About the Team

Join a world-class team at the forefront of AI and biochemistry.

At Genesis Therapeutics, we’re a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers. Our shared mission is nothing short of revolutionary: to forge the next generation of AI foundation models that will unlock groundbreaking therapies for patients with severe diseases.

We don’t just apply machine learning to biology; we are conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, pushing the boundaries of each field. You will work side-by-side with top multidisciplinary researchers to design and build generative foundation models at scale, having access to ample compute and large-scale simulations.

About the Role

This is an opportunity to operate as a full member of our research team and to drive forward our ML research agenda for generative modeling of molecular systems. You will be paired with a mentor to work on a high-impact research project at the frontier of generative AI. Your work will likely involve making advancements to novel foundation models, with potential projects in areas like diffusion models, large language models (LLMs), reinforcement learning (RL), and multi-modal learning. We’re looking for exceptional PhD candidates passionate about conducting novel research that contributes directly to our mission of discovering new medicines.

You Will

Lead a novel research project from ideation to conclusion, focused on a critical challenge in generative or predictive AI for molecular systems.
Push the research frontier by engaging with the latest literature on foundation models, developing new methods in areas like diffusion or RL, and rigorously testing your hypotheses at scale.
Design and run experiments at scale to validate most promising approaches and hypotheses.
Present your work to the team and contribute your insights to our broader research agenda. Strong internship projects may lead to publications in top-tier venues.

You Are

Currently enrolled in a PhD program in Computer Science, Machine Learning, or related fields.
A creative researcher with a strong background in machine learning, deep learning, and/or related areas.
A first-principles thinker who is passionate about tackling open-ended scientific problems.
Curious about the intersection of AI and biochemistry and excited to learn about the drug discovery process.

What we offer

A high-impact research project, not a toy problem. Your work is chosen to have a direct line of sight to advancing our core scientific platform.
Dedicated mentorship from a senior researcher on our team who will partner with you, guide your project, and champion your growth.
Deep immersion in a world-class team. You'll join our paper discussions, research talks, and social events, becoming a true member of the Genesis AI team. The team reads and discusses 1-2 ML or chemistry papers every week to stay on top of the field and inspire new ideas.

Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.

Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets.

The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI-focused platform collaborations with major pharmaceutical companies, including most recently Incyte Corporation (Feb 2025) and Gilead Sciences (Sept 2024).

We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures.

Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.

View all jobs at Genesis Therapeutics

View Genesis Therapeutics Profile

Report Job

Similar Jobs

Virtu Financial

Software Engineer

Information Technology • Financial Services

In-Office

New York, NY, USA

822 Employees

130K-180K Annually

Revivn

Engineering Manager

Greentech • Information Technology • Social Impact • Software

Easy Apply

In-Office

Brooklyn, NY, USA

120 Employees

190K-215K Annually

Eve

AI Outcomes Manager

Legal Tech • Software • Generative AI

Easy Apply

Remote or Hybrid

United States

180 Employees

Findigs, Inc.

Operations Associate

Fintech • Real Estate • Software • PropTech

Easy Apply

Hybrid

New York, NY, USA

65 Employees

105K-120K Annually

Get Personalized Job Insights.

Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company

HQ: Burlingame, CA

58 Employees

What We Do

Genesis Therapeutics is unifying AI and biotech to accelerate and optimize drug discovery. We pioneer novel deep learning and molecular simulation techniques to accelerate the development of new medicines. Genesis raised its $52M Series A from top tech + biotech investors, Andreessen Horowitz, Rock Springs, and T. Rowe Price. Story: https://techcrunch.com/2020/12/02/genesis-therapeutics-raises-52m-a-round-for-its-ai-focused-drug-discovery-mission/ We deploy our technology to accelerate a pipeline of several internal drug programs. Furthermore, Genesis has announced two significant, multi-target collaborations with Genentech and with Eli Lilly, the latter of which entailed a $20M upfront payment with a $670M total deal size. Now we are scaling the team and technology to support many more programs in parallel as well as increasingly difficult protein targets. We currently have a team (genesistherapeutics.ai/company.html#team) of about 35 people, split 50/50 between our ML / software team and our biochem team of veteran drug hunters in our own wetlab space. Our ML + software engineers are top-notch -- many graduates from MIT, UC Berkeley, Stanford. Previously worked at OpenAI, Google, Facebook, MemSQL, Jane Street, Dropbox, etc. We're recruiting pure ML research scientists + software engineers (no bio or chem experience expected) to further our core AI platform as well as scale our drug pipeline. Likewise, we have several openings in chemistry and biology to join our team of biotech + pharma veterans who are deploying the Genesis ML platform to discover novel drug candidates. Please apply on our website, or feel free to reach out via email directly: [email protected]